| abstract |
The present invention provides the metabolite of palonosetron or its pharmaceutically acceptable salt or its prodrug which can be used to treat animals, especially human, of formula (I): wherein R and R independently may be H, hydroxyl or carbonyl; and wherein R may be of formula ( II) or formula (III) |